What is Fertility Tourism? A Complete Guide

Section 01

What is Fertility Tourism?

Fertility tourism, more precisely termed cross-border reproductive care (CBRC) in academic and clinical literature, refers to the movement of patients across national borders to access assisted reproductive technologies (ART) that are restricted, unavailable, or prohibitively expensive in their home country. Unlike most other health tourism sub-sectors, where cost is the dominant driver, fertility tourism is fundamentally shaped by legal variation: the same procedure may be legal in one EU member state and illegal in the neighbouring one.

Fertility tourism is unique among health tourism sub-sectors in that legislation, rather than cost, is often the primary reason a patient crosses a border. The treatment they need exists. The problem is that their country will not permit it.

The scale of cross-border reproductive care in Europe is significant. Research published in academic reproductive medicine literature estimates that cross-border IVF cycles account for approximately 5% of all ART procedures carried out in Europe annually. Spain, the Czech Republic, and Cyprus are the most common destination countries for patients from the UK, Germany, France, Italy, and Scandinavia.

Beyond Europe, global fertility tourism encompasses patients from Australia and the US travelling to Canada or Eastern Europe for surrogacy, patients from East Asia seeking donor egg programmes in Southeast Asia and Europe, and patients from conservative regulatory environments accessing treatments unavailable at home.

Section 02

Why People Travel for Reproductive Care

The motivations behind fertility tourism are more varied and often more personal than other forms of health travel. Four primary drivers account for the majority of cross-border reproductive care.

Legal restrictions at home

Procedures such as egg donation, anonymous sperm donation, surrogacy, post-menopausal IVF, and treatment for same-sex couples are legal in some countries and prohibited in others. Patients travel to access treatments their home country does not permit rather than forgo them entirely.

Cost

IVF and donor egg cycles in Western Europe and North America are expensive relative to Eastern European and Southeast Asian alternatives. A donor egg cycle in the Czech Republic or Cyprus can cost 50-60% less than equivalent treatment in the UK or Germany, with no observable difference in clinical outcomes at reputable clinics.

Waiting times and donor availability

Egg donor waiting lists in the UK can extend to one to three years due to the legal requirement for identifiable donors. Countries with larger donor pools and different legal frameworks offer substantially shorter waiting times, often measured in weeks rather than years.

Access to specific expertise or technology

Some patients travel for access to specific clinical approaches, genetic testing methodologies, or laboratory technologies not available in their home country. A smaller but growing segment seeks second opinions or specialist consultations at internationally recognised reproductive medicine centres.

Section 03

Common Fertility Tourism Treatments

IVF and ICSI

In vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI) are the most common treatments sought across borders. Patients may travel for standard IVF when home country costs are prohibitive or waiting times excessive, and particularly for IVF involving donor eggs or sperm where legal or availability constraints apply domestically.

Egg Donation

Egg donation is the single largest driver of fertility tourism within Europe. The UK's requirement for identifiable donors, combined with a shortage of willing donors under those conditions, creates long waiting lists. Spain, the Czech Republic, and Cyprus operate under frameworks that historically allowed anonymous donation, have large established donor pools, and can match patients within weeks. Regulatory frameworks are evolving and patients should verify current laws directly with their chosen clinic.

Surrogacy

Surrogacy is among the most legally complex areas of reproductive travel. Commercial surrogacy is prohibited in most European countries but legal in several others. Altruistic surrogacy rules vary widely. The legal status of the intended parents and the child after birth depends on the laws of both the destination country and the parents' home country, and these do not always align. Legal advice from a specialist in international family law is essential for anyone considering cross-border surrogacy.

Preimplantation Genetic Testing

Preimplantation genetic testing (PGT) for chromosomal abnormalities or specific genetic conditions is permitted in some countries and prohibited or restricted in others. Patients whose home country restricts PGT for non-medical reasons may travel to access this technology as part of an IVF cycle.

Fertility Preservation

Egg freezing, sperm freezing, and embryo banking are sought cross-border primarily for cost reasons, as storage costs and cycle fees vary substantially between markets. Medical preservation before cancer treatment is the most common clinical indication; elective preservation for social reasons is an increasingly significant driver in younger patient demographics.

Section 04

Top Fertility Tourism Destinations

Destination	Primary Treatments	Key Source Markets	Legal Framework
Spain	Egg donation, IVF, ICSI, embryo donation	UK, Germany, France, Italy, GCC	Permissive for egg and sperm donation; anonymous donation legally shifting; strong regulatory oversight
Czech Republic	Egg donation, IVF, embryo donation, PGT	UK, Germany, Austria, Scandinavia	Large established donor pool; historically anonymous donation; competitive pricing
Cyprus	Egg donation, IVF, surrogacy (regulated)	UK, Germany, France, GCC	Permissive framework for egg donation and gestational surrogacy; active oversight ongoing
Greece	Egg donation, IVF, embryo donation	UK, Germany, Italy, GCC	Well-regulated framework; identifiable donation approach being phased in; experienced clinic network
Ukraine	Surrogacy, egg donation, IVF	Italy, Spain, France, Germany	Commercial surrogacy historically available for heterosexual couples; significant disruption since 2022
USA	Gestational surrogacy, IVF, egg donation	Global high-net-worth patients, same-sex couples from markets with restrictions	Permissive for commercial surrogacy in certain states; highest clinical standards; highest costs
Canada	Altruistic surrogacy, IVF, egg donation	USA, UK, Australia, Europe	Altruistic surrogacy legal; well-regulated; high clinical standards; cost advantage vs US
Thailand	IVF, fertility preservation, PGT	Australia, UK, China, Southeast Asia	Regulatory framework tightened post-2015; restrictions on commercial surrogacy; IVF and egg donation available

Legal frameworks governing reproductive care are subject to change. Patients should verify the current regulatory position with their chosen clinic and, for complex situations involving surrogacy or multi-jurisdiction parentage questions, seek advice from a specialist reproductive law solicitor before commencing treatment.

Section 05

Ethical Considerations in Fertility Tourism

Fertility tourism raises ethical questions that are more acute than in most other health tourism sub-sectors, and patients, clinicians, and policymakers are still working through the implications.

Donor Welfare and Compensation

Egg donation is physically demanding and carries medical risk. The distinction between reasonable compensation for time, inconvenience, and medical risk, and payments that create financial coercion, is not universally agreed and is drawn differently across jurisdictions. Patients travelling to access donors in lower-income countries should consider whether the compensation structure at their chosen clinic treats donors fairly and screens appropriately for medical and psychological fitness.

Donor Anonymity and Donor-Conceived Persons' Rights

The right of donor-conceived individuals to access information about their biological origins is increasingly recognised in national legislation across Europe and beyond. Patients choosing anonymous donation in a jurisdiction that permits it may find that their home country, or the destination country, subsequently changes its laws, potentially affecting their child's future rights. The trend across European jurisdictions is toward identifiable donation, and patients making choices today should consider the longer-term implications for any child born of their treatment.

Surrogacy and Exploitation

Commercial surrogacy in lower-income markets raises concerns about whether surrogates are genuinely free to make informed decisions, adequately protected legally, and fairly compensated. The involvement of intermediary agencies adds further complexity. Patients pursuing surrogacy abroad should research the regulatory oversight in their destination country, the legal protections afforded to the surrogate, and the legal status of the intended parents and child in both countries before entering any arrangement.

Legal Parentage Across Borders

The legal status of a child born through cross-border surrogacy or donor treatment may not be automatically recognised in the parents' home country. Intended parents may need to pursue adoption or parental order proceedings after the child's birth to establish legal parentage under home country law. The complexity of this process varies enormously by jurisdiction and should be understood in full before treatment commences.

Section 06

How to Choose a Fertility Tourism Provider

Verify the clinic's success rates for your specific treatment type and patient age group, and understand how those figures are calculated and reported
Confirm the treating reproductive specialist's qualifications, training, and years of experience with your specific procedure
Ask about the clinic's laboratory standards, embryology team experience, and the testing methodologies used for PGT if applicable
Obtain a detailed written treatment protocol and cost estimate covering all stages, including medication, monitoring, embryo transfer, and storage fees
Understand the donor screening process in detail, including medical, genetic, and psychological assessment, if treatment involves donated gametes
Confirm the clinic's policy on the number of embryos transferred and their approach to multiple pregnancy risk
Understand the legal framework in the destination country for your specific treatment and the implications for your home country
For surrogacy, obtain independent legal advice in both the destination country and your home country before proceeding
Confirm what support the clinic provides if a cycle fails and what the protocol is for subsequent attempts
Ensure your home country fertility specialist receives complete records of your treatment protocol, medication history, and cycle outcomes

Frequently Asked Questions

Fertility Tourism: Common Questions

Fertility tourism, also called cross-border reproductive care (CBRC), involves travelling to another country to access fertility treatments that are legally restricted, unavailable, too expensive, or subject to long waiting times in the patient's home country. It is one of the fastest-growing sub-sectors of health tourism and is driven as much by legal variation between countries as by cost differentials.

The four main reasons are legal restrictions on certain procedures in the home country (particularly egg donation, donor anonymity rules, treatment for single women or same-sex couples, and surrogacy), cost savings of 40-60% compared to Western European and North American pricing, shorter waiting times for egg donors in countries with larger donor pools, and in some cases access to specific clinical expertise or genetic testing technology not available domestically.

Spain is the most popular fertility tourism destination for European patients, particularly for egg donation, due to its large donor pool, experienced clinic network, and strong regulatory framework. The Czech Republic and Cyprus are also major destinations for egg donation, with shorter waiting times and competitive pricing. For surrogacy, the legal framework matters as much as the clinical offering: the US offers the most robust legal protections, Canada is well regulated for altruistic surrogacy, and patients should verify the current legal position in any destination country before proceeding.

Safety and success rates at reputable fertility clinics in Spain, the Czech Republic, Greece, and Cyprus are comparable to those at leading UK and German clinics. The key variables are laboratory quality, embryology team experience, and the treating specialist's expertise, not the country. Patients should ask for age-stratified success rates for their specific treatment type and compare these with published national and European averages before choosing a clinic.

Legal issues arise from the fact that reproductive laws vary substantially across countries, and the legal framework of the destination country does not automatically determine rights and obligations in the home country. Key legal questions include donor anonymity and the donor-conceived person's right to identifying information; legal parentage for children born through surrogacy; the recognition of parentage established abroad under home country law; and the legal status of imported embryos or donated gametes. Patients should seek advice from a reproductive law specialist in their home country before beginning treatment abroad, particularly for surrogacy or any situation involving gamete donation.

Surrogacy laws vary enormously by country, and legality in the destination country does not mean the arrangement will be recognised in the intended parents' home country. Commercial surrogacy is legal in certain US states, legal with restrictions in Canada (altruistic only), and prohibited in most European countries. The legal status of the child and the intended parents' parental rights after birth depend on both countries' laws, which may conflict. Patients considering surrogacy abroad should obtain independent legal advice in both jurisdictions before entering any arrangement.

A standard IVF cycle in the UK costs approximately £4,000-6,000 at a private clinic, excluding medication. In Spain, the Czech Republic, or Greece, a comparable cycle typically costs £2,500-4,000 including medication. For donor egg cycles, the difference is more pronounced: a UK donor egg cycle can cost £8,000-15,000 depending on the clinic and donor matching costs, while equivalent treatment in Spain or the Czech Republic typically runs £4,000-7,000. Even after flights and accommodation, the savings on a donor egg cycle are usually substantial.